Simplexa Group A Strep Direct Kit
Simplexa Group A Strep Direct Kit
Background
Group A Streptococcus is responsible for common infections, such as strep throat, and may cause up to 30% of acute pharyngitis cases in children and up to 20% of cases in adults. Patients may present with symptoms that overlap extensively with other infectious diseases, which makes diagnosis difficult when based solely on clinical observation. The benefits of quality molecular testing continue to gain momentum as an alternative to culture and rapid antigen testing as they provide definitive answers without supplemental testing.
Why to choose it
A CLIA moderate complexity assay using throat swabs. Improved efficiency with a true sample-to-answer workflow without DNA extraction providing results in about an hour.
Benefits
High Performance
In a study of over 1,300 prospective samples, the Simplexa Group A Strep Direct demonstrated high performance with excellent clinical agreement against culture methods.
| Name | Sensitivity | Specificity |
| Prospective Samples | 97.4% (152/156) 95% CI: 93.6% to 99% | 95.2% (1139/1196) 95% CI: 93.9% to 96.3% |
Fast Turn-Around-Time
Our Simplexa Group A Strep assay takes only about an hour to generate high-quality results without the need for culturing.
For use on
Ordering Info
| PRODUCT | CODE | REACTIONS |
Simplexa Group A Strep Direct Kit * Direct Amplification Discs included in kit | MOL2850 | 24 |
Simplexa Group A Strep Positive Control Pack | MOL2860 | 10x100uL |
Please click below for more information
- Product: Simplexa Group A Strep Direct Kit
- SKU:
- Availability: In Stock